Digital Therapeutics
SKU
MRR-431752EA4722
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 6.42 billion
2030
USD 33.16 billion
2024
USD 8.05 billion
CAGR
26.42%

Digital Therapeutics Market by Component (Devices, Software & Services), Application (Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease) - Global Forecast 2024-2030

[198 Pages Report] The Digital Therapeutics Market size was estimated at USD 6.42 billion in 2023 and expected to reach USD 8.05 billion in 2024, at a CAGR 26.42% to reach USD 33.16 billion by 2030.

Digital Therapeutics Market
To learn more about this report, request a free PDF copy

Digital therapeutics, abbreviated as DTx, refers to a branch of digital health that encompasses a range of software-driven therapeutic interventions designed to prevent, manage, or treat a medical disorder or disease. Digital therapeutics are developed on the basis of clinical evidence and often undergo rigorous regulatory review. They are intended to be used independently or in conjunction with traditional medical treatments, and they provide patients, healthcare providers, and payers with data-driven, personalized approaches to enhance patient care and health outcomes. The digital therapeutics market is growing with the escalation of chronic diseases, rising healthcare costs, and advancements in healthcare technologies. Increasing smartphone penetration and the acceptance of telehealth services also contribute to the adoption of this technology. The demand for personalized and preventive healthcare solutions further strengthens the market's progress. However, the market faces considerable challenges, including regulatory hurdles, patient data security concerns, and the need for clinical validation of digital therapeutic applications. Amidst these challenges, the integration of digital therapeutics with electronic health records (EHRs) and the potential of AI and machine learning pave the way for innovation and the future growth of the digital therapeutics market.

Digital Therapeutics Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Component: Growing significance of data analysis software and compliance services

Devices in digital therapeutics are often wearables, sensors, and other types of biomedical hardware that collect patient data. These devices can track a wide array of health metrics, such as physical activity, sleep patterns, and blood glucose levels. Need-based preference in devices leans towards user-friendliness, accuracy, and seamless integration with software applications. Software & services are seen as the core of digital therapeutics. This segment consists of platforms, applications, and professional services that deliver therapeutic interventions. Preference is given to scalability, interoperability, patient engagement, and data security of software and services.

Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring

Digital therapeutic solutions aimed at cardiovascular diseases often include applications that monitor heart rate, blood pressure, and cardiovascular health-related habits. Need-based preference for these solutions is high among patients with a history of heart disease and those at risk due to genetic factors or lifestyle. The central nervous system disorder application segment includes digital therapeutics for diseases including Parkinson's, Alzheimer's, depression, and ADHD. DTx solutions here aim at cognitive rehabilitation, behavior therapy, and medication management. Need-based preference is particularly strong among individuals seeking non-pharmacological interventions. Digital therapeutics in chronic respiratory diseases offer tools for asthma and COPD management, including inhaler tracking, symptom tracking, and environmental trigger alerts. These are preferred by patients needing continuous monitoring and those looking to manage disease exacerbations. Digital solutions for diabetes focus on blood glucose monitoring, insulin dosage tracking, and lifestyle coaching. Preference for diabetes management apps is high owing to the need for daily management and monitoring. Medication adherence applications of DTx aim to tackle the challenge of patients not taking their medications as prescribed. This need is ubiquitous across all patient categories but is particularly critical in the management of chronic diseases. Digital therapeutics for musculoskeletal disorders offer exercise programs, pain management techniques, and physical therapy guidance. They are highly preferred by patients seeking remote or supplemental treatment to traditional therapy. Digital therapeutic strategies for obesity include personalized nutrition, physical activity tracking, and behavior modification programs. The need in this segment is driven by the global rise in obesity rates and the associated health risks. Digital therapeutics for prediabetes focus on lifestyle interventions to prevent the onset of type 2 diabetes. These applications are useful for individuals identified as having prediabetes to delay or prevent disease progression. For smoking cessation, digital therapeutics include quit plans, tracking of progress, and counseling support. These tools have a high preference among those trying to quit smoking, often complementing nicotine replacement therapies.

Regional Insights

In the Americas, the market for digital therapeutics is robust, underpinned by progressive regulatory frameworks, significant venture capital investments, and growing partnerships between DTx companies and healthcare providers. The United States Food and Drug Administration (FDA) has been creating a conducive environment for DTx products through clear guidance and approvals for prescription DTx, which are seen as important steps toward integrating these solutions into standard healthcare practices. Europe's digital therapeutics market is marked by a strong emphasis on evidence-based solutions and is driven by a diverse healthcare landscape where countries are adopting various approaches to integrate DTx into their healthcare systems. Initiatives such as Germany's Digital Healthcare Act (DVG), which allows doctors to prescribe digital health applications, exemplify the supportive regulatory environment. The Middle East and Africa, while still at nascent stages, are expected to witness growth, largely propelled by mobile-based health initiatives and partnerships aiming to improve access to healthcare services. The APAC region shows vast potential for digital therapeutics, although the market presents a heterogeneous mix of economic, cultural, and technological readiness. Countries, including Japan and Singapore, are at the forefront of adopting DTx, with favorable regulatory pathways and initiatives for digital health innovation. In other areas, such as India and China, rising smartphone penetration and government initiatives to support digital health ecosystems are creating opportunities for DTx expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Digital Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

    BehaVR and Fern Health have announced a strategic merger, forming RealizedCare, a digital care management platform focused on revolutionizing chronic pain treatment. As a convergence of pioneering digital therapeutic technology and traditional services, RealizedCare positions itself to overhaul value-based chronic pain management. By amalgamating BehaVR's expertise in creating validated immersive digital therapeutics and Fern Health's previously established chronic pain programs with industry leaders, RealizedCare aims to scale personalized interventions, bolstering outcomes and providing comprehensive support for pain management. [Published On: 2023-11-16]

  • Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes

    Better Therapeutics, Inc., a company in the field of prescription digital therapeutics, announces the market introduction of AspyreRx, an innovative cognitive behavioral therapy application. This trailblazing digital tool, which holds FDA Class II authorization, is designed exclusively for adults grappling with type 2 diabetes (T2D). AspyreRx stands out as the initial app-based solution substantiated by rigorous randomized controlled trial data demonstrating significant, enduring reductions in A1c, with additional benefits including improved blood pressure, weight management, mood, and overall quality of life. [Published On: 2023-10-16]

  • Lumanity Joins The Digital Therapeutics Alliance

    Lumanity has aligned with the Digital Therapeutics Alliance (DTA), a global non-profit organization dedicated to the progression of digital therapeutics (DTx). As a member of the DTA, Lumanity is set to contribute to the Alliance's fundamental vision of democratizing access to quality, evidence-backed digital therapy options for patients and stakeholders in the health sector. This partnership embodies the synergistic potential to elevate patient care by incorporating clinically proven digital therapies into conventional medical practice, championing both clinical excellence and healthcare economic improvement. [Published On: 2023-08-08]

Key Company Profiles

The report delves into recent significant developments in the Digital Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 2morrow Inc., Akili Interactive Labs, Inc., Ayogo Health Inc., Better Therapeutics, Inc., Big Health, Inc., Biofourmis Inc., Canary Health Technologies Inc., Click Therapeutics, Inc., Cognoa, Inc., DarioHealth Corp., Fern Health, Inc., Fitterfly Healthtech Private Limited, Happify, Inc., Headspace Inc., Kaia Health Software Inc., Lark Technologies, Inc., Lumanity Inc., MedRhythms, Noom, Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health by ResMed Corp., SilverCloud by American Well Corporation, Voluntis by AptarGroup, Inc., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Devices
    • Software & Services
  • Application
    • Cardiovascular Disease
    • Central Nervous System Disorder
    • Chronic Respiratory Disease
    • Diabetes
    • Medication Adherence
    • Musculoskeletal Disorder
    • Obesity
    • Prediabetes
    • Smoking Cessation

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Digital Therapeutics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital Therapeutics Market?
  3. What are the technology trends and regulatory frameworks in the Digital Therapeutics Market?
  4. What is the market share of the leading vendors in the Digital Therapeutics Market?
  5. Which modes and strategic moves are suitable for entering the Digital Therapeutics Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Increasing incidences of chronic diseases and lifestyle-related health issues
        2. Government initiatives promoting telehealth and telemedicine
        3. Adoption of smartphones and tablets coupled with healthcare apps
      2. Restraints
        1. Limited awareness regarding digital therapeutics in developing economies
      3. Opportunities
        1. Advent of computing and artificial intelligence in digital therapeutics
        2. Rising funding and investments for digital health businesses
      4. Challenges
        1. Issues pertaining to data privacy and security
    2. Market Segmentation Analysis
      1. Component: Growing significance of data analysis software and compliance services
      2. Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Digital Therapeutics Market, by Component
    1. Introduction
    2. Devices
    3. Software & Services
  7. Digital Therapeutics Market, by Application
    1. Introduction
    2. Cardiovascular Disease
    3. Central Nervous System Disorder
    4. Chronic Respiratory Disease
    5. Diabetes
    6. Medication Adherence
    7. Musculoskeletal Disorder
    8. Obesity
    9. Prediabetes
    10. Smoking Cessation
  8. Americas Digital Therapeutics Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  9. Asia-Pacific Digital Therapeutics Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  10. Europe, Middle East & Africa Digital Therapeutics Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  11. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
      1. BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
      2. Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
      3. Lumanity Joins The Digital Therapeutics Alliance
  12. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  13. List of Figures [Total: 20]
    1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
    2. DIGITAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
    3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. DIGITAL THERAPEUTICS MARKET DYNAMICS
    7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
    8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    11. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    12. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    14. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    15. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    16. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    17. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
    20. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
  14. List of Tables [Total: 206]
    1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2024-2030 (USD MILLION)
    31. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2024-2030 (USD MILLION)
    33. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    34. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    35. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    36. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    37. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    38. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    39. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    40. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    41. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    42. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    43. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    44. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    45. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    46. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    47. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    48. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    49. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    50. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    51. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    52. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    53. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    54. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    55. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    56. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    57. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    58. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    59. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    60. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    61. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    62. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    63. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    64. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    65. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    66. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    67. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    68. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    69. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    70. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    71. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    72. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    73. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    74. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    75. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    76. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    77. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    78. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    79. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    80. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    81. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    82. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    83. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    84. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    85. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    86. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    87. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    88. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    89. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    90. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    91. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    92. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    93. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    94. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    95. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    96. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    97. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    98. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    99. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    100. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    101. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    102. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    103. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    104. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    105. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    106. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    107. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    108. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    109. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    110. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    111. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    112. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    113. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    114. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    115. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    116. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    117. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    118. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    119. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    120. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    121. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    122. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    123. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    124. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    125. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    126. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    127. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    128. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    129. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    130. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    131. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    132. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    133. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    134. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    135. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    136. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    137. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    138. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    139. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    140. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    141. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    142. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    143. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    144. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    145. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    146. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    147. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    148. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    149. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    150. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    151. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    152. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    153. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    154. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    155. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    156. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    157. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    158. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    159. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    160. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    161. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    162. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    163. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    164. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    165. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    166. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    167. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    168. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    169. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    170. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    171. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    172. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    173. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    174. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    175. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    176. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    177. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    178. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    179. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    180. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    181. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    182. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    183. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    184. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    185. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    186. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    187. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    188. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    189. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    190. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    191. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    192. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    193. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    194. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    195. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    196. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    197. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    198. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    199. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    200. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    201. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
    202. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
    203. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    204. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    205. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
    206. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
  15. List of Companies Mentioned [Total: 25]
    1. 2morrow Inc.
    2. Akili Interactive Labs, Inc.
    3. Ayogo Health Inc.
    4. Better Therapeutics, Inc.
    5. Big Health, Inc.
    6. Biofourmis Inc.
    7. Canary Health Technologies Inc.
    8. Click Therapeutics, Inc.
    9. Cognoa, Inc.
    10. DarioHealth Corp.
    11. Fern Health, Inc.
    12. Fitterfly Healthtech Private Limited
    13. Happify, Inc.
    14. Headspace Inc.
    15. Kaia Health Software Inc.
    16. Lark Technologies, Inc.
    17. Lumanity Inc.
    18. MedRhythms
    19. Noom, Inc.
    20. Omada Health Inc.
    21. Pear Therapeutics, Inc.
    22. Propeller Health by ResMed Corp.
    23. SilverCloud by American Well Corporation
    24. Voluntis by AptarGroup, Inc.
    25. Welldoc, Inc.
Frequently Asked Questions
  1. How big is the Digital Therapeutics Market?
    Ans. The Global Digital Therapeutics Market size was estimated at USD 6.42 billion in 2023 and expected to reach USD 8.05 billion in 2024.
  2. What is the Digital Therapeutics Market growth?
    Ans. The Global Digital Therapeutics Market to grow USD 33.16 billion by 2030, at a CAGR of 26.42%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.